Hussey Peter S, Schneider Eric C, Rudin Robert S, Fox D Steven, Lai Julie, Pollack Craig Evan
RAND Corporation, Santa Monica, California.
RAND Corporation, Santa Monica, California2Division of General Medicine and Primary Care, Brigham and Women's Hospital, Harvard Medical School, and Harvard School of Public Health, Boston, Massachusetts.
JAMA Intern Med. 2014 May;174(5):742-8. doi: 10.1001/jamainternmed.2014.245.
Better continuity of care is expected to improve patient outcomes and reduce health care costs, but patterns of use, costs, and clinical complications associated with the current patterns of care continuity have not been quantified.
To measure the association between care continuity, costs, and rates of hospitalizations, emergency department visits, and complications for Medicare beneficiaries with chronic disease.
DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study of insurance claims data for a 5% sample of Medicare beneficiaries experiencing a 12-month episode of care for congestive heart failure (CHF, n = 53,488), chronic obstructive pulmonary disease (COPD, n = 76,520), or type 2 diabetes mellitus (DM, n = 166,654) in 2008 and 2009.
Hospitalizations, emergency department visits, complications, and costs of care associated with the Bice-Boxerman continuity of care (COC) index, a measure of the outpatient COC related to conditions of interest.
The mean (SD) COC index was 0.55 (0.31) for CHF, 0.60 (0.34) for COPD, and 0.50 (0.32) for DM. After multivariable adjustment, higher levels of continuity were associated with lower odds of inpatient hospitalization (odds ratios for a 0.1-unit increase in COC were 0.94 [95% CI, 0.93-0.95] for CHF, 0.95 [0.94-0.96] for COPD, and 0.95 [0.95-0.96] for DM), lower odds of emergency department visits (0.92 [0.91-0.92] for CHF, 0.93 [0.92-0.93] for COPD, and 0.94 [0.93-0.94] for DM), and lower odds of complications (odds ratio range, 0.92-0.96 across the 3 complication types and 3 conditions; all P < .001). For every 0.1-unit increase in the COC index, episode costs of care were 4.7% lower for CHF (95% CI, 4.4%-5.0%), 6.3% lower for COPD (6.0%-6.5%), and 5.1% lower for DM (5.0%-5.2%) in adjusted analyses.
Modest differences in care continuity for Medicare beneficiaries are associated with sizable differences in costs, use, and complications.
预期更好的医疗连续性可改善患者预后并降低医疗成本,但与当前医疗连续性模式相关的使用模式、成本及临床并发症尚未得到量化。
衡量患有慢性病的医疗保险受益人的医疗连续性、成本与住院率、急诊就诊率及并发症之间的关联。
设计、设置与参与者:对2008年和2009年患有充血性心力衰竭(CHF,n = 53488)、慢性阻塞性肺疾病(COPD,n = 76520)或2型糖尿病(DM,n = 166654)且经历了12个月护理期的5%医疗保险受益人样本的保险理赔数据进行回顾性队列研究。
与Bice - Boxerman医疗连续性(COC)指数相关的住院、急诊就诊、并发症及护理成本,该指数用于衡量与相关疾病有关的门诊COC。
CHF的平均(标准差)COC指数为0.55(0.31),COPD为0.60(0.34),DM为0.50(0.32)。多变量调整后,更高的连续性水平与较低的住院几率相关(COC指数每增加0.1个单位,CHF的比值比为0.94 [95%CI,0.93 - 0.95],COPD为0.95 [0.94 - 0.96],DM为0.95 [0.95 - 0.96]),较低的急诊就诊几率(CHF为0.92 [0.91 - 0.92],COPD为0.93 [0.92 - 0.93],DM为0.94 [0.93 - 0.94]),以及较低的并发症几率(3种并发症类型和3种疾病的比值比范围为0.92 - 0.96;所有P < 0.001)。在调整分析中,COC指数每增加0.1个单位,CHF的护理期成本降低4.7%(95%CI,4.4% - 5.0%),COPD降低6.3%(6.0% - 6.5%),DM降低5.1%(5.0% - 5.2%)。
医疗保险受益人的医疗连续性存在适度差异与成本、使用及并发症方面的显著差异相关。